Cargando…

Retinal microvasculature alteration in patients with systemic sclerosis and chloroquine treatment

BACKGROUND: Retinal vascular abnormality is an important part of ocular systemic sclerosis (SSc), and long-term use of chloroquine can lead to retinal toxicity. This study was conducted to evaluate retinal microvascular changes using optical coherence tomography angiography (OCTA) in patients with S...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Tao, Liang, Rong-Bin, Zhang, Li-Juan, Shu, Hui-Ye, Ge, Qian-Min, Liao, Xu-Lin, Wu, Jie-Li, Su, Ting, Pan, Yi-Cong, Zhou, Qiong, Shao, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511431/
https://www.ncbi.nlm.nih.gov/pubmed/36185048
http://dx.doi.org/10.21037/qims-21-1166
_version_ 1784797640950546432
author Huang, Tao
Liang, Rong-Bin
Zhang, Li-Juan
Shu, Hui-Ye
Ge, Qian-Min
Liao, Xu-Lin
Wu, Jie-Li
Su, Ting
Pan, Yi-Cong
Zhou, Qiong
Shao, Yi
author_facet Huang, Tao
Liang, Rong-Bin
Zhang, Li-Juan
Shu, Hui-Ye
Ge, Qian-Min
Liao, Xu-Lin
Wu, Jie-Li
Su, Ting
Pan, Yi-Cong
Zhou, Qiong
Shao, Yi
author_sort Huang, Tao
collection PubMed
description BACKGROUND: Retinal vascular abnormality is an important part of ocular systemic sclerosis (SSc), and long-term use of chloroquine can lead to retinal toxicity. This study was conducted to evaluate retinal microvascular changes using optical coherence tomography angiography (OCTA) in patients with SSc and SSc patients on long-term chloroquine treatment. METHODS: Fifteen SSc patients without chloroquine (30 eyes), 15 SSc patients taking long-term chloroquine (30 eyes) and 15 healthy controls (30 eyes) were recruited to this cross-sectional study. OCTA was used to examine the superficial and deep retinal capillary plexus in the macular retina of each eye. The densities of microvessels (MIR), macrovessels (MAR) and total microvessels (TMI) in the superficial and deep retina of the three groups were calculated and compared. We used the hemisphere segmentation method [superior right (SR), superior left (SL), inferior left (IL), and inferior right (IR)] and Early Treatment Diabetic Retinopathy Study (ETDRS) method [right (R), superior (S), left (L), and inferior (I)] to analyze changes in retinal microvascular density. RESULTS: The superficial and deep retinal MIR density in SSc patients decreased (P<0.05) compared with the healthy control group. This significant difference was found in both superficial and deep layers in S, L, SR, SL and IL regions (P<0.05), and additionally in the R and I regions in the superficial layer (P<0.05). Similarly, compared with SSc patients who did not take chloroquine, the superficial and deep retinal MIR density of SSc patients on long-term chloroquine also decreased (P<0.05). This significant difference was found in both superficial and deep layers in R, I and IL regions (P<0.05), and additionally in the IR region in the superficial layer (P<0.05). CONCLUSIONS: The OCTA results suggest that retinal MIR density is decreased in SSc patients, and that long-term use of chloroquine will aggravate this damage, resulting in a further decrease in retinal MIR density.
format Online
Article
Text
id pubmed-9511431
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-95114312022-10-01 Retinal microvasculature alteration in patients with systemic sclerosis and chloroquine treatment Huang, Tao Liang, Rong-Bin Zhang, Li-Juan Shu, Hui-Ye Ge, Qian-Min Liao, Xu-Lin Wu, Jie-Li Su, Ting Pan, Yi-Cong Zhou, Qiong Shao, Yi Quant Imaging Med Surg Original Article BACKGROUND: Retinal vascular abnormality is an important part of ocular systemic sclerosis (SSc), and long-term use of chloroquine can lead to retinal toxicity. This study was conducted to evaluate retinal microvascular changes using optical coherence tomography angiography (OCTA) in patients with SSc and SSc patients on long-term chloroquine treatment. METHODS: Fifteen SSc patients without chloroquine (30 eyes), 15 SSc patients taking long-term chloroquine (30 eyes) and 15 healthy controls (30 eyes) were recruited to this cross-sectional study. OCTA was used to examine the superficial and deep retinal capillary plexus in the macular retina of each eye. The densities of microvessels (MIR), macrovessels (MAR) and total microvessels (TMI) in the superficial and deep retina of the three groups were calculated and compared. We used the hemisphere segmentation method [superior right (SR), superior left (SL), inferior left (IL), and inferior right (IR)] and Early Treatment Diabetic Retinopathy Study (ETDRS) method [right (R), superior (S), left (L), and inferior (I)] to analyze changes in retinal microvascular density. RESULTS: The superficial and deep retinal MIR density in SSc patients decreased (P<0.05) compared with the healthy control group. This significant difference was found in both superficial and deep layers in S, L, SR, SL and IL regions (P<0.05), and additionally in the R and I regions in the superficial layer (P<0.05). Similarly, compared with SSc patients who did not take chloroquine, the superficial and deep retinal MIR density of SSc patients on long-term chloroquine also decreased (P<0.05). This significant difference was found in both superficial and deep layers in R, I and IL regions (P<0.05), and additionally in the IR region in the superficial layer (P<0.05). CONCLUSIONS: The OCTA results suggest that retinal MIR density is decreased in SSc patients, and that long-term use of chloroquine will aggravate this damage, resulting in a further decrease in retinal MIR density. AME Publishing Company 2022-10 /pmc/articles/PMC9511431/ /pubmed/36185048 http://dx.doi.org/10.21037/qims-21-1166 Text en 2022 Quantitative Imaging in Medicine and Surgery. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Huang, Tao
Liang, Rong-Bin
Zhang, Li-Juan
Shu, Hui-Ye
Ge, Qian-Min
Liao, Xu-Lin
Wu, Jie-Li
Su, Ting
Pan, Yi-Cong
Zhou, Qiong
Shao, Yi
Retinal microvasculature alteration in patients with systemic sclerosis and chloroquine treatment
title Retinal microvasculature alteration in patients with systemic sclerosis and chloroquine treatment
title_full Retinal microvasculature alteration in patients with systemic sclerosis and chloroquine treatment
title_fullStr Retinal microvasculature alteration in patients with systemic sclerosis and chloroquine treatment
title_full_unstemmed Retinal microvasculature alteration in patients with systemic sclerosis and chloroquine treatment
title_short Retinal microvasculature alteration in patients with systemic sclerosis and chloroquine treatment
title_sort retinal microvasculature alteration in patients with systemic sclerosis and chloroquine treatment
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511431/
https://www.ncbi.nlm.nih.gov/pubmed/36185048
http://dx.doi.org/10.21037/qims-21-1166
work_keys_str_mv AT huangtao retinalmicrovasculaturealterationinpatientswithsystemicsclerosisandchloroquinetreatment
AT liangrongbin retinalmicrovasculaturealterationinpatientswithsystemicsclerosisandchloroquinetreatment
AT zhanglijuan retinalmicrovasculaturealterationinpatientswithsystemicsclerosisandchloroquinetreatment
AT shuhuiye retinalmicrovasculaturealterationinpatientswithsystemicsclerosisandchloroquinetreatment
AT geqianmin retinalmicrovasculaturealterationinpatientswithsystemicsclerosisandchloroquinetreatment
AT liaoxulin retinalmicrovasculaturealterationinpatientswithsystemicsclerosisandchloroquinetreatment
AT wujieli retinalmicrovasculaturealterationinpatientswithsystemicsclerosisandchloroquinetreatment
AT suting retinalmicrovasculaturealterationinpatientswithsystemicsclerosisandchloroquinetreatment
AT panyicong retinalmicrovasculaturealterationinpatientswithsystemicsclerosisandchloroquinetreatment
AT zhouqiong retinalmicrovasculaturealterationinpatientswithsystemicsclerosisandchloroquinetreatment
AT shaoyi retinalmicrovasculaturealterationinpatientswithsystemicsclerosisandchloroquinetreatment